Cibc World Markets Corp Takes Position in Maximus, Inc. (NYSE:MMS)

Cibc World Markets Corp purchased a new position in Maximus, Inc. (NYSE:MMS) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 5,629 shares of the health services provider’s stock, valued at approximately $420,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. UMB Bank n.a. increased its stake in Maximus by 79.8% in the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock worth $27,000 after purchasing an additional 158 shares during the period. Eastern Bank bought a new position in shares of Maximus in the fourth quarter worth about $29,000. V Square Quantitative Management LLC increased its stake in Maximus by 65.9% in the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock worth $34,000 after buying an additional 180 shares during the period. R Squared Ltd bought a new stake in Maximus during the 4th quarter valued at about $54,000. Finally, IFP Advisors Inc grew its stake in Maximus by 62.4% in the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock worth $59,000 after acquiring an additional 302 shares in the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on MMS. StockNews.com downgraded shares of Maximus from a “buy” rating to a “hold” rating in a research note on Friday, February 14th. Raymond James raised Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price for the company in a research report on Thursday, January 2nd.

Maximus Stock Down 0.1 %

Shares of Maximus stock opened at $67.12 on Monday. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The stock has a market cap of $3.80 billion, a price-to-earnings ratio of 14.43 and a beta of 0.71. The firm’s 50-day moving average is $71.07 and its two-hundred day moving average is $78.47. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.97.

Maximus (NYSE:MMS) last released its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. As a group, research analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Saturday, February 15th were given a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.79%. The ex-dividend date was Friday, February 14th. Maximus’s payout ratio is 25.81%.

Insider Buying and Selling

In other news, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the transaction, the insider now owns 2,512 shares of the company’s stock, valued at $171,167.68. The trade was a 85.23 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Jan Madsen sold 2,439 shares of the business’s stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the transaction, the director now owns 18,097 shares of the company’s stock, valued at approximately $1,225,347.87. This trade represents a 11.88 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by company insiders.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.